GSK picks Kevin Sims to lead business development for pharma R&D

GlaxoSmithKline have named Kevin Sim as Senior Vice President and head of worldwide business development for pharma R & D.

Commenting on this news, Kevin said “The incredible pace of scientific and technical innovation that is happening around the world is significant, and presents an abundance of opportunities to combine GSK’s strengths and capabilities with that of others, to pursue big ideas in science and medicine. I look forward to working with the team to explore collaborations that can accelerate the discovery and development of new medicines with the potential to significantly improve human health.”

Kevin currently works for Genentech where he is Global Head of Oncology and Business Development. He will be joining GSK in July.